PRF1 and neoplasm: Encapsulation of specific molecules, such as drugs and genetic agents like CRISPR/Cas9, siRNA, and mRNA, into nanocarriers with tumor targeting strategy has led to address PFP resistance and represents promising strategy for effective induction of PANoptosis in specific cancer models.